Join to View Full Profile
5323 Harry Hines BoulevardDallas, TX 75390
Phone+1 214-645-2800
Fax+1 214-648-7121
Dr. Hegde is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Brigham and Women's HospitalPost-Doctoral Fellowship, 2014 - 2016
Harvard School of Public HealthMPH, 2016
University of Wisconsin Hospitals and ClinicsFellowship, Cardiovascular Disease, 2011 - 2014
Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 2007 - 2010
University of Kansas School of MedicineClass of 2007
Certifications & Licensure
MA State Medical License 2014 - 2027
TX State Medical License 2025 - 2026
WI State Medical License 2011 - 2015
MO State Medical License 2010 - 2012
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Cardiovascular Disease
Publications & Presentations
PubMed
- 1 citationsAficamten in Obstructive Hypertrophic Cardiomyopathy: A Multidomain, Patient-Level Analysis of the MAPLE-HCM Trial.Andrew Wang, Pablo Garcia-Pavia, Ahmad Masri, Bela Merkely, Michael E Nassif
Journal of the American College of Cardiology. 2026-03-03 - 2 citationsSafety and Efficacy of Aficamten in Patients With Nonobstructive Hypertrophic Cardiomyopathy: A 96-Week Analysis From FOREST-HCM.Ahmad Masri, Mark V Sherrid, Lubna Choudhury, Pablo Garcia-Pavia, Christopher M Kramer
Journal of Cardiac Failure. 2026-02-01 - Effect of Aficamten in Women Compared With Men With Obstructive Hypertrophic Cardiomyopathy in SEQUOIA-HCM.Xiaowen Wang, Maria A Pabon, Tracy T Makuvire, Reziwanguli Maimaiti, Theodore P Abraham
Circulation. Heart Failure. 2026-01-01
Journal Articles
- Effect of High-Dose Trivalent vs Standard-Dose Quadrivalent Influenza Vaccine on Mortality or Cardiopulmonary Hospitalization in Patients with High-Risk Cardiovascular...Jacob A Udell, Sheila M Hegde, Deepak L Bhatt, J Michael Gaziano, Kristin Nichol, Matthew C Tattersall, Jonathan L Temte, Clyde Yancy, JAMA
- Sudden Death in Heart Failure with Preserved Ejection FractionScot D. Solomon, Sheila M. Hegde, Nancy K. Sweitzer, Sanjiv J. Shah, James C. Fang, Akshay S. Desai, ScienceDirect
Press Mentions
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025September 1st, 2025- Effect of Aficamten Compared with Metoprolol on Cardiac Structure and Function in Symptomatic Obstructive Hypertrophic Cardiomyopathy: A Prespecified Analysis of MAPLE-HCMAugust 31st, 2025
- Mavacamten Improves Cardiac Structure, Function in Obstructive Hypertrophic CardiomyopathyDecember 29th, 2021
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
